Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Presentation THT 2025

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

Presenter: Jonathan Weinsaft

February 12, 2025

Presentation THT 2025

AI Echo's Potential to Transform HF Management

Presenter: Carolyn Lam

February 12, 2025

Presentation THT 2025

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Presenter: Jonathan Cunningham

February 12, 2025

Presentation THT 2025

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Presenter: Akhil Narang

February 12, 2025

Presentation THT 2025

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Presenter: Ralph von Bardeleben

February 12, 2025

Presentation THT 2025

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Presenter: Rebecca Hahn

February 12, 2025

Presentation THT 2025

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Presenter: Jeffrey Teuteberg

February 12, 2025

Presentation THT 2025

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

Presenter: Joao Cavalcante

February 12, 2025

Presentation THT 2025

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

Presenter: Daniel Bensimhon

February 12, 2025

Presentation THT 2025

When to Use a Form of Replacement Therapies

Presenter: Maria Rosa Costanzo

February 12, 2025

Presentation THT 2025

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation THT 2025

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

Presenter: G. Michael Felker

February 12, 2025

Presentation THT 2025

When and Why Are Diuretics Sometimes Just Not Enough?

Presenter: Jennifer Cowger

February 12, 2025

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Advertisement

Imaging for Assessing Heart Muscle Disease: State of the Art for Trial Endpoints, Drug Development and Clinical Practice

AI Echo's Potential to Transform HF Management

HFpEF: Can Image Phenotyping Help for Prognostication and Therapy DEevelopment

Use of AI-Based Automated Detection of Clinically Significant VHD From Echocardiography

Lessons Learned From RESHAPE-HF-2: An Imager's Perspective

Strengths and Weaknesses of VHD Quantitation in Clinical Research and Daily Practice

Challenges in Designing Collaborative Clinical Therapeutic Trials in HT

Ventricular Remodeling as an Endpoint for HF Trials: Methods, Comparative Precision, Real-World Applicability

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

When to Use a Form of Replacement Therapies

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

When to Use Devices the Recude Renal Vein Pressure

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

When and Why Are Diuretics Sometimes Just Not Enough?

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Harnessing Real World Data to Test Emerging Technologies

Time to Escalation: From the Golden Day to the Golden Six Hours

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Optimizing Outcomes in Cardiac Arrest and Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content